Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine add-on to sertraline for post-breakup depression in women
IRCT20100105002999N10Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of clonidine and sertraline in major depressive disorder (MDD) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Severity of attachment and suffering from detachment. Started Feb 2018; status: completed.
02
Drugs
clonidinesertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20100105002999N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100105002999N10.